Literature DB >> 33630836

Number of people requiring post-exposure prophylaxis to end leprosy: A modeling study.

Anneke T Taal1,2, David J Blok2, Wim H van Brakel1, Sake J de Vlas2, Jan Hendrik Richardus2.   

Abstract

BACKGROUND: Worldwide, around 210,000 new cases of leprosy are detected annually. To end leprosy, i.e. zero new leprosy cases, preventive interventions such as contact tracing and post-exposure prophylaxis (PEP) are required. This study aims to estimate the number of people requiring PEP to reduce leprosy new case detection (NCD) at national and global level by 50% and 90%. METHODOLOGY/PRINCIPAL
FINDINGS: The individual-based model SIMCOLEP was fitted to seven leprosy settings defined by NCD and MB proportion. Using data of all 110 countries with known leprosy patients in 2016, we assigned each country to one of these settings. We predicted the impact of administering PEP to about 25 contacts of leprosy patients on the annual NCD for 25 years and estimated the number of contacts requiring PEP per country for each year. The NCD trends show an increase in NCD in the first year (i.e. backlog cases) followed by a significant decrease thereafter. A reduction of 50% and 90% of new cases would be achieved in most countries in 5 and 22 years if 20.6 and 40.2 million people are treated with PEP over that period, respectively. For India, Brazil, and Indonesia together, a total of 32.9 million people requiring PEP to achieve a 90% reduction in 22 years. CONCLUSION/SIGNIFICANCE: The leprosy problem is far greater than the 210,000 new cases reported annually. Our model estimates of the number of people requiring PEP to achieve significant reduction of new leprosy cases can be used by policymakers and program managers to develop long-term strategies to end leprosy.

Entities:  

Year:  2021        PMID: 33630836      PMCID: PMC7906365          DOI: 10.1371/journal.pntd.0009146

Source DB:  PubMed          Journal:  PLoS Negl Trop Dis        ISSN: 1935-2727


  29 in total

1.  Global leprosy situation, 2006.

Authors: 
Journal:  Wkly Epidemiol Rec       Date:  2006-08-11

2.  Protective effect of the combination BCG vaccination and rifampicin prophylaxis in leprosy prevention.

Authors:  Ron P Schuring; Jan Hendrik Richardus; David Pahan; Linda Oskam
Journal:  Vaccine       Date:  2009-09-26       Impact factor: 3.641

3.  SIMLEP: a simulation model for leprosy transmission and control.

Authors:  A Meima; M D Gupte; G J van Oortmarssen; J D Habbema
Journal:  Int J Lepr Other Mycobact Dis       Date:  1999-09

4.  Household and dwelling contact as risk factors for leprosy in northern Malawi.

Authors:  P E Fine; J A Sterne; J M Pönnighaus; L Bliss; J Saui; A Chihana; M Munthali; D K Warndorff
Journal:  Am J Epidemiol       Date:  1997-07-01       Impact factor: 4.897

Review 5.  Leprosy: the epidemiology of a slow bacterium.

Authors:  P E Fine
Journal:  Epidemiol Rev       Date:  1982       Impact factor: 6.222

6.  Effectiveness of single dose rifampicin in preventing leprosy in close contacts of patients with newly diagnosed leprosy: cluster randomised controlled trial.

Authors:  F Johannes Moet; David Pahan; Linda Oskam; Jan H Richardus
Journal:  BMJ       Date:  2008-03-10

7.  Leprosy services in primary health care in India: comparative economic cost analysis of two public-health settings.

Authors:  Anuj Tiwari; David J Blok; Pramilesh Suryawanshi; Akash Raikwar; Mohammad Arif; Jan Hendrik Richardus
Journal:  Trop Med Int Health       Date:  2018-12-06       Impact factor: 2.622

8.  Antimicrobial resistance in leprosy: results of the first prospective open survey conducted by a WHO surveillance network for the period 2009-15.

Authors:  E Cambau; P Saunderson; M Matsuoka; S T Cole; M Kai; P Suffys; P S Rosa; D Williams; U D Gupta; M Lavania; N Cardona-Castro; Y Miyamoto; D Hagge; A Srikantam; W Hongseng; A Indropo; V Vissa; R C Johnson; B Cauchoix; V K Pannikar; E A W D Cooreman; V R R Pemmaraju; L Gillini
Journal:  Clin Microbiol Infect       Date:  2018-03-01       Impact factor: 8.067

9.  Forecasting the new case detection rate of leprosy in four states of Brazil: A comparison of modelling approaches.

Authors:  David J Blok; Ronald E Crump; Ram Sundaresh; Martial Ndeffo-Mbah; Alison P Galvani; Travis C Porco; Sake J de Vlas; Graham F Medley; Jan Hendrik Richardus
Journal:  Epidemics       Date:  2017-03       Impact factor: 4.396

10.  Policy Lessons From Quantitative Modeling of Leprosy.

Authors:  Graham F Medley; David J Blok; Ronald E Crump; T Déirdre Hollingsworth; Alison P Galvani; Martial L Ndeffo-Mbah; Travis C Porco; Jan Hendrik Richardus
Journal:  Clin Infect Dis       Date:  2018-06-01       Impact factor: 9.079

View more
  4 in total

Review 1.  Modulation of the Response to Mycobacterium leprae and Pathogenesis of Leprosy.

Authors:  Natasha Cabral; Vilma de Figueiredo; Mariana Gandini; Cíntia Fernandes de Souza; Rychelle Affonso Medeiros; Letícia Miranda Santos Lery; Flávio Alves Lara; Cristiana Santos de Macedo; Maria Cristina Vidal Pessolani; Geraldo Moura Batista Pereira
Journal:  Front Microbiol       Date:  2022-06-02       Impact factor: 6.064

2.  Cost-effectiveness of incorporating Mycobacterium indicus pranii vaccine to multidrug therapy in newly diagnosed leprosy cases for better treatment outcomes & immunoprophylaxis in contacts as leprosy control measures for National Leprosy Eradication Programme in India.

Authors:  Malaisamy Muniyandi; Malkeet Singh; Manjula Singh; Kavitha Rajshekhar; Kiran Katoch
Journal:  Indian J Med Res       Date:  2021-07       Impact factor: 2.375

3.  Delayed detection of leprosy cases: A systematic review of healthcare-related factors.

Authors:  Yudhy Dharmawan; Ahmad Fuady; Ida J Korfage; Jan Hendrik Richardus
Journal:  PLoS Negl Trop Dis       Date:  2022-09-06

4.  Less is more: Developing an approach for assessing clustering at the lower administrative boundaries that increases the yield of active screening for leprosy in Bihar, India.

Authors:  Nimer Ortuño-Gutiérrez; Pin-Wei Shih; Aashish Wagh; Shivakumar Mugudalabetta; Bijoy Pandey; Bouke C de Jong; Jan Hendrik Richardus; Epco Hasker
Journal:  PLoS Negl Trop Dis       Date:  2022-09-12
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.